At Luminous Labs, innovation is at the heart of everything we do, and protecting those innovations is equally vital. That’s why our partnership with Matthys Squire, a leading intellectual property (IP) law firm, and Attorney Andreas Witzke, a specialist in European and international IP law, marks a pivotal chapter in our journey. Together, we’re safeguarding the groundbreaking work that’s shaping the future of photobiomodulation and female health optimization.
Matthys Squire: A Legacy of Intellectual Property Excellence
Matthys Squire stands as a global leader in intellectual property law, with over a century of expertise in patents, trademarks, and designs. Their reputation for tailoring solutions to innovative industries, including healthcare, engineering, and technology, is unmatched.
- Global Reach: Serving clients in diverse sectors across the globe.
- Expert Team: A multidisciplinary approach that combines legal and technical expertise to protect innovations.
- Commitment to Growth: Helping organizations leverage IP to secure competitive advantages.
Their role in Luminous Labs’ journey has been instrumental in securing the foundation of our intellectual property portfolio.
Introducing Attorney Andreas Witzke
Andreas Witzke, a partner at Matthys Squire, brings decades of experience in navigating the complexities of IP law. His deep understanding of technology and health-focused industries makes him the perfect ally for Luminous Labs.
- Professional Expertise: Specializes in drafting, filing, and prosecuting patents and trademarks with a focus on highly competitive markets.
- Innovative Guidance: Has been a trusted advisor in helping us protect our unique light therapy technologies and trademarks.
Andreas’s expertise has ensured that our innovations, such as Cellight Technology™, remain protected as we continue to push boundaries in wellness and longevity.
Achievements So Far
Trademarking Milestones
- Cellight™: Successfully trademarked, solidifying our proprietary light mixture tailored for individual photobiomodulation needs.
- Additional Trademarks: Ongoing efforts to protect the Luminous Labs brand and products, ensuring a strong, recognizable identity.
Patent Success
- First Patent Filed: Focused on Cellight Technology™, securing protection for its unique light mixture and individualized therapy applications.
- Building a Strong IP Base: Our first patent marks a milestone in safeguarding the science behind personalized photobiomodulation.
What’s Next: Expanding Innovation and Protection
Future Trademarks
We’re working to protect the Luminous Labs name and our flagship product, Kini, reinforcing our identity as a leader in innovative wellness technologies.
Second Patent Submission
Our second patent focuses on advancing personalized photobiomodulation spectra, deepening the potential for individualized light therapy solutions. This effort leverages cutting-edge design and engineering to elevate the science behind our devices.
Looking Ahead
Our collaboration with Matthys Squire and Andreas Witzke reflects our commitment to innovation and protection:
- Game-Changing Solutions: Individualized light therapy dosage represents the future of photobiomodulation, and we’re leading the way.
- Expanding Our IP Portfolio: By securing patents and trademarks, we’re laying the groundwork for sustainable growth and innovation.
A Heartfelt Thank You
We extend our deepest gratitude to Matthys Squire and Attorney Andreas Witzke for their exceptional expertise and unwavering support. Their contributions have been instrumental in helping us turn visionary ideas into protected realities.
As we continue to innovate, we’re proud to have such esteemed partners by our side. Together, we’re lighting the way forward—one innovation at a time.
Want to learn more?
- Explore Matthys Squire.
- Connect with Andreas Witzke on LinkedIn.
Stay connected with our journey by following us on Instagram. Let’s shape the future of wellness together.
